Table 1.
Basic and clinical characteristics of patients in the three groups
| Variables | I + V group | I + B group | I group | P |
|---|---|---|---|---|
| Sex | ||||
| Male | 40 (61.5%) | 38 (58.5%) | 31 (47.7%) | 0.248 |
| Female | 25 (38.5%) | 27 (41.5%) | 34 (52.3%) | |
| Age (years) | 45.52±14.67 | 40.38±13.64 | 44.45±15.21 | 0.106 |
| BMI (kg/m2) | 25.11±3.43 | 25.07±3.24 | 24.81±3.63 | 0.450 |
| Cause of Intubation | ||||
| Trauma | 21 (31.8%) | 30 (46.2%) | 38 (58.5%) | 0.075 |
| Loss of Consciousness | 21 (31.8%) | 17 (26.2%) | 17 (26.2%) | |
| Surgery | 17 (25.8%) | 13 (20.0%) | 6 (9.2%) | |
| Poisoning | 7 (10.6%) | 5 (7.7%) | 4 (6.2%) | |
| Intubation time (days) | 7.63±6.11 | 9.03±6.64 | 8.69±7.06 | 0.455 |
Data is presented as n (%) or Mean±SD. I + V group: Received ipratropium bromide and budesonide via a nebulizer. I + B group: In addition to ipratropium bromide, received the violet flower extract syrup. I group: Received ipratropium bromide alone via a nebulizer